Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss NVAX - Novavax, Inc.
2.72 M
LAST VALUE
100.30%
2 YEAR CAGR
17.54%
5 YEAR CAGR
12.49%
10 YEAR CAGR